Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Text Message and Mail Delivery of Tailored Educational Materials to Improve Access to Resources for Smoking Cessation of Menthol Tobacco Cigarettes

28. september 2026 oppdatert av: Roswell Park Cancer Institute

An Exploratory Investigation on Effectiveness of Tailored New York State Quitline Services for Cessation of Menthol Tobacco Cigarettes

This clinical trial compares the impact of receiving educational materials containing relevant content about risks from smoking menthol cigarettes which include links to the New York (NY) Smoke-Free website by text message or mail in people who smoke menthol cigarettes. The NY Smoke-Free website includes tailored content developed specifically for menthol smokers and provides resources designed to resonate with the experiences of menthol smokers and address the unique challenges they face in quitting. Delivering tailored educational materials by text message or mail may increase interaction with information about menthol cigarettes and smoking cessation resources compared to those who do not receive the educational messaging.

Studieoversikt

Detaljert beskrivelse

PRIMARY OBJECTIVES:

I. Assess participant interaction with an educational message about menthol cigarettes by tracking visits to the Quitline website.

II. Assess participant interaction with the educational message delivered by text message with a direct link to information about menthol cigarettes by tracking visits to the Quitline Web site.

III. Assess participant interaction with the educational message delivery by mail with a direct link to information about menthol cigarettes by tracking visits to the Quitline Web.

OUTLINE: Participants are randomized to 1 of 3 groups.

GROUP I: Participants receive an educational flyer by mail along with the standard Quitline materials on study. Participants receive access to a website and quick response (QR) code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.

GROUP II: Participants receive standard Quitline materials in the mail on study.

GROUP III: Participants receive an educational message by text along with the standard Quitline materials by mail on study. Participants receive access to a website and QR code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.

Studietype

Intervensjonell

Registrering (Antatt)

600

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • New York
      • Buffalo, New York, Forente stater, 14263
        • Roswell Park Cancer Institute

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Adults aged 18 years or older
  • Residents of New York State
  • English Speaking
  • Willingness to receive and engage with mailed educational materials
  • Participants with ability to receive text messaging access to smart device

Exclusion Criteria:

  • Report currently smoking menthol cigarettes
  • People who do not report currently smoking menthol cigarettes
  • Individuals under 18 years of age
  • Persons in correctional facilities
  • Non-English speaking
  • Participants who cannot receive text messaging or have access to smart device

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Cohort II (standard Quitline materials)

Participants receive standard Quitline materials in the mail on study.

Receive standard Quitline materials

Andre navn:
  • Røyking og tobakksavvenningsintervensjoner
Eksperimentell: Group I (educational material by mail)

Participants receive an educational flyer by mail along with the standard Quitline materials on study. Participants receive access to a website and QR code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.

Receive standard Quitline materials

Andre navn:
  • Røyking og tobakksavvenningsintervensjoner

Receive an educational flyer by mail

Andre navn:
  • Utdanning for intervensjon
  • Intervensjon fra utdanning
  • Intervensjon gjennom utdanning
  • Intervensjon, pedagogisk

Receive access to a website

Receive access to a QR code

Andre navn:
  • Smartphone App-based Intervention
  • Smartphone Intervention
  • Smartphone-based Intervention
Eksperimentell: Group III (educational messaging by text)

Participants receive an educational message by text along with the standard Quitline materials by mail on study. Participants receive access to a website and QR code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.

Receive standard Quitline materials

Andre navn:
  • Røyking og tobakksavvenningsintervensjoner

Receive access to a website

Receive access to a QR code

Andre navn:
  • Smartphone App-based Intervention
  • Smartphone Intervention
  • Smartphone-based Intervention

Receive an educational message by text

Andre navn:
  • Automatisert tekstmeldingsbasert navigering
  • Tekstmeldingsbasert navigering

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Engagement with quick response (QR) code scans
Tidsramme: Up to 12 months

QR code will be scanned will be tracked through unique uniform resource locator assigned. Each scan will be documented, allowing for the counting of interactions (Poisson) directly affiliated with the materials distributed. Also, binary (yes/no) (Did the participant interact at least once). Will be analyzed using chi-square tests or Fisher's exact tests. Bonferroni's correction will be used to adjust for three pairwise comparisons (alpha=0.05/3).

Up to 12 months
Website Utilization
Tidsramme: Up to 12 months

total number of visits, unique visitors,

Up to 12 months
Interactions with online resources
Tidsramme: Up to 12 months

Interactions with online resources will include the number of clicks on website, and time spent on various pages. Will be analyzed using chi-square tests or Fisher's exact tests. Bonferroni's correction will be used to adjust for three pairwise comparisons (alpha=0.05/3).

Up to 12 months
Website utilization
Tidsramme: Up to 12 months

Duration of sessions

Up to 12 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Number of website interactions from the mailed flyer
Tidsramme: Up to 12 months

Will measure participant engagement with the menthol educational materials.

Up to 12 months
Number of QR code interactions from the mailed flyer
Tidsramme: Up to 12 months

Will measure participant engagement with the menthol educational materials.

Up to 12 months
Number of website interactions from the text message
Tidsramme: Up to 12 months

Will measure participant engagement with the menthol educational materials.

Up to 12 months
Number of QR code interactions from the text message
Tidsramme: Up to 12 months

Will measure participant engagement with the menthol educational materials.

Up to 12 months
Duration spent on the cessation website
Tidsramme: Up to 12 months

Will assess depth of engagement.

Up to 12 months
Number of pages or resources accessed on the website
Tidsramme: Up to 12 months

Will evaluate participant utilization of the content.

Up to 12 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Sarah Pearson-Collins, Roswell Park Cancer Institute

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

8. august 2025

Primær fullføring (Faktiske)

12. desember 2025

Studiet fullført (Antatt)

12. desember 2026

Datoer for studieregistrering

Først innsendt

21. september 2026

Først innsendt som oppfylte QC-kriteriene

28. september 2026

Først lagt ut (Faktiske)

5. oktober 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

5. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

28. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • I-4464925
  • NCI-2025-03221 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
  • I-4464925 (Annen identifikator: Roswell Park Cancer Institute)

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere